KWILP
ENTA icon

Kiwi Wealth Investments Limited Partnership’s Enanta Pharmaceuticals ENTA Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,380
Closed -$390K – 187
2022
Q4 		$390K Buy
+8,380
New +$382K 0.03% 192

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's ENTA Position: Q1 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of Enanta Pharmaceuticals (ENTA) in Q1 2023, closing a stake of 8,380 shares — an estimated $390K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in ENTA in Q4 2022 and held it in 1 quarter. The position peaked at $390K in Q4 2022. 145 funds tracked by Wall St. Rank hold ENTA as of Q1 2023.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Enanta Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 8,380 Enanta Pharmaceuticals shares in Q1 2023, an estimated $390K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Enanta Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Enanta Pharmaceuticals position peaked at $390K in Q4 2022.
  • 145 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q1 2023, filed 16 May 2023.